Fig 2.
(A) Overall survival (OS) rates based on the baseline European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Lung Cancer 13 (EORTC QLQ LC-13) dyspnea score (5-year OS of 15% v 19% for EORTC QLQ LC-13 dyspnea scores above and below the median level, respectively). (B) OS rates based on the baseline EORTC QLQ-C30 physical functioning score (5-year OS of 23% v 12% for EORTC QLQ-C30 physical functioning scores above and below the median level, respectively).